Maha Katabi
InvestorGeneral Partner at Sofinnova Ventures
Montreal
Writes $100K – $5M checks · typically $1.5M
About
Maha Katabi is a PhD in Pharmacology and CFA who built crossover public/private biotech investing platforms, focuses on clinical‑stage single‑asset radiopharmaceutical and targeted oncology companies, and chairs Exactis Innovation.
Invests in
BiotechHealthtechMedical Devices
Deals · 5
Marea Therapeutics, Inc.Board seat
via Sofinnova Ventures · filed Jun 2024 · $160.4M raise
Gyroscope Therapeutics LtdBoard seat
via Sofinnova Ventures · filed Apr 2021 · $148M raise
Aerovate Therapeutics, Inc.Board seat
via Sofinnova Ventures · filed Aug 2020 · $75.8M raise
Apellis Pharmaceuticals, Inc.Board seat
via Sofinnova Ventures · filed Aug 2017 · $60.1M raise
Effector TherapeuticsBoard seat
via Sofinnova Ventures · filed Feb 2016 · $56M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Sofinnova Ventures
Network1
Investors connected to Maha in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Maha Katabi work?
- Maha Katabi is General Partner at Sofinnova Ventures.
- What does Maha Katabi invest in?
- Maha Katabi invests in Biotech, Healthtech, Medical Devices.
- What check size does Maha Katabi write?
- Maha Katabi typically writes checks of $100K – $5M.









